Free Trial

Reni J. Analyst Performance

Analyst at JMP Securities

Reni J. is a stock analyst at JMP Securities in the medical sector, covering 5 publicly traded companies. Over the past year, Reni J. has issued 6 stock ratings, including buy and hold recommendations. While full access to Reni J.'s proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Reni J.'s coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
6 Last 0 Years
Buy Recommendations
83.33% 5 Buy Ratings
Companies Covered
5 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy83.3%5 ratings
Hold16.7%1 ratings
Sell0.0%0 ratings

Out of 6 total stock ratings issued by Reni J. at JMP Securities, the majority (83.3%) have been Buy recommendations, followed by 16.7% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
5 companies

Reni J., an analyst at JMP Securities, currently covers 5 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
100.0%

Reni J. of JMP Securities specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
3 companies
60.0%
MED - DRUGS
2 companies
40.0%

Reni J.'s Ratings History at JMP Securities

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/3/2025Reiterated Rating$24.15$40.00Market Outperform
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
8/19/2025Reiterated Rating$26.29$40.00Market Outperform
Prelude Therapeutics Incorporated stock logo
PRLD
Prelude Therapeutics
8/18/2025Lower Price Target$0.87$3.00Market Outperform
BioAtla, Inc. stock logo
BCAB
BioAtla
8/13/2025Reiterated Rating$0.38Market Perform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
8/12/2025Lower Price Target$7.46$10.00Market Outperform
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
8/11/2025Lower Price Target$5.54$24.00Market Outperform